2m 2m 2m 2m 2m 2m 2m
Aldeyra Therapeu (ALDX)
NASDAQ
$2.06+$0.04 (+2.18%)
Price as of Jun 23, 2026 7:56 PM EDT- $123.7MMarket Cap
- -39.70%1-Year Change
- BiotechnologyIndustry
Aldeyra Therapeu (ALDX)
$2.06+$0.04 (+2.18%)
ALDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.02 | ||
Change | -$0.03 (-1.46%) | ||
Open | $2.00 | ||
High | $2.21 | ||
Low | $2.00 | ||
Previous Close | $2.05 | ||
Volume | 2,434,659 | ||
30-Day Average Volume | 1,267,721 | ||
1-Week Change | 13.48% | ||
1-Month Change | 30.32% | ||
1-Year Change | -39.70% | ||
3-Year Change | -71.59% | ||
5-Year Change | -82.01% | ||
Fundamentals | |||
Shares Outstanding | 60.3M | ||
Total Assets | $66.5M | ||
Market Cap | $123.7M | ||
Enterprise Value | $74.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.5M | ||
Free Cash Flow | -$5.1M | ||
EBIT | -$3.5M | ||
EBITDA | -$3.4M | ||
Net Working Capital | $41.9M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -22 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -34 | ||
PEG | -1 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue